Director · Nurix Therapeutics, Inc. · Nurix Therapeutics, Inc. — Director Stock Option (right to buy)
Side
A
Value
—
Shares
50.0K
Price
—
Executed
Nov 6, 2025
Disclosed
Nov 10, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Nov 6 executedNov 10, 2025 disclosed
NRIX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Nurix Therapeutics, Inc. — Director Stock Option (right to buy)
Ticker
NRIX
Shares
50.0K
Price per share
$0
Execution date (reported)
Nov 6, 2025
Owned after transaction
50.0K shares
Days from execution to publication
4
What this establishes
Dansey Roger D filed this Form 4 reporting a grant or award of NRIX on Nov 6, 2025. It became public on Nov 10, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Dansey Roger Dcik:0001741836
Issuer
Nurix Therapeutics, Inc.cik:0001549595
Revision history · 0
No field has changed since this record was first ingested.
